Figure 2
Figure 2. Model of human NK-cell development. (1) Bone marrow–derived CD34+CD45RA+ HPCs circulate in the blood and (2) extravasate across lymph node high endothelial venules to enter the parafollicular space. There, (3) pro-NK cells are activated to progress through distinct stages of maturation (far right) to create both CD56bright and CD56dim NK cells.31 Maturing CD56dim NK cells return to the circulation via the efferent lymph (4),32 whereas some CD56bright NK cells remain within the secondary lymphoid tissue to interact with DCs (5).21,23,33,34 Illustration by Debra T. Dartez.

Model of human NK-cell development. (1) Bone marrow–derived CD34+CD45RA+ HPCs circulate in the blood and (2) extravasate across lymph node high endothelial venules to enter the parafollicular space. There, (3) pro-NK cells are activated to progress through distinct stages of maturation (far right) to create both CD56bright and CD56dim NK cells.31  Maturing CD56dim NK cells return to the circulation via the efferent lymph (4),32  whereas some CD56bright NK cells remain within the secondary lymphoid tissue to interact with DCs (5).21,23,33,34  Illustration by Debra T. Dartez.

Close Modal

or Create an Account

Close Modal
Close Modal